Table_3_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

“…On the contrary, disease-modifying therapy (DMT) (OR=1.3, 95% CrI: 0.31 to 5.0) and tacrolimus (TAC) (OR=5.9, 95% CrI: 0.19 to 310) would increase the incidence of relapse. …”

DataSheet_1_Metataxonomic and Metabolic Impact of Fecal Microbiota Transplantation From Patients With Pancreatic Cancer Into Germ-Free Mice: A Pilot Study.docx by Laurence Genton (9989290)

“…</p>Methods<p>We transplanted the feces from five PC patients and five age- and gender-matched healthy volunteers into two GF mice each. …”

Network evolution in the presence of oscillating hub. by Samuel Goldman (1699888)

“…</b> 10 different simulations with <i>N</i> = 500, <i>γ</i> = 1.9, show that the network can learn a maximum of 7 different target functions associated with 7 input frequencies before a loss in performance. To decrease variance emerging from trial-to-trial variability, behavior is averaged over 30 trials for 1–3 targets, 20 trials for 4–5 targets, and 10 trials for 6–7 targets. …”

Table_4_Effectiveness and tolerability of different therapies in preventive treatment of MOG-IgG-associated disorder: A network meta-analysis.docx by Xiaofei Wang (135107)

“…On the contrary, disease-modifying therapy (DMT) (OR=1.3, 95% CrI: 0.31 to 5.0) and tacrolimus (TAC) (OR=5.9, 95% CrI: 0.19 to 310) would increase the incidence of relapse. …”

Image_1_Cardiac resynchronization therapy in heart failure patients by using left bundle branch pacing.TIF by Ying Gu (203149)

“…LBB capture threshold and R-wave amplitude remained stable at 12-month follow-up when compared with implantation values (0.62 ± 0.13 V @ 0.4 ms vs. 0.73 ± 0.21 V @ 0.4 ms, 12.02 ± 5.68 mV vs. 8.58 ± 4.09 mV, respectively). …”

Table_2_Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials.DOCX by Dongjiao An (10904472)

“…The weighted mean difference of MADRS score was observed to decrease by 6.16 (95% CI 4.44–7.88) in 2–4 h, 9.96 (95% CI 8.97–10.95) in 24 h, and 4.09 (95% CI 2.18–6.00) in 28 day. …”

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012 by Abigail Doucette (2601559)

“…UB rates increased in all high-risk groups except for a 22.5% decrease among higher-risk CHD. Among high-risk infants, mechanical ventilation increased through 2012 to 20.4% and 13.5% of RSV and UB hospitalizations; geometric mean cost increased to $31,742 and $25,962, respectively, and RSV mortality declined to 0.9%.…”

Image_8_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

“…The pooled results showed that compared with control treatment, S1P receptor agonists [mean difference (MD): −6.80; 95% confidence interval (CI): −8.23 to −5.38; p<0.00001], and sphingosine kinase 2 inhibitors (MD: −0.95; 95% CI: −1.26 to −0.65; p<0.00001) alleviated psoriasis-like dermatitis in mice. …”

Table_1_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.docx by Liu Liu (512237)

“…The pooled results showed that compared with control treatment, S1P receptor agonists [mean difference (MD): −6.80; 95% confidence interval (CI): −8.23 to −5.38; p<0.00001], and sphingosine kinase 2 inhibitors (MD: −0.95; 95% CI: −1.26 to −0.65; p<0.00001) alleviated psoriasis-like dermatitis in mice. …”

An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients by Elizabeth Colston (3998495)

“…Fourteen participants (58.3%) had an increase from baseline HIV-1 RNA (mean, 0.87 log₁₀ copies/mL; range, 0.59–1.29). …”

Preferential down-regulation of miRNAs and overexpression of XY genes in GCKO testis samples by P18. by Anne R. Greenlee (304274)

Knockdown of transcription factors, SP1 and EGR1, attenuates miR-27a expression. by Bum-Yong Kang (350760)

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

VZV infection affects the integrity of the epidermis by disrupting the desmosomal junctions. by Meleri Jones (517263)

“…<p>From the RNA-seq dataset the average fold change (KCV/KC) show that genes associated with the desmosomes (<b>A</b>) were significantly downregulated (*p<0.01) in differentiated keratinocytes after VZV infection. …”

Effects of Plasma Membrane Cholesterol Level and Cytoskeleton F-Actin on Cell Protrusion Mechanics by Nima Khatibzadeh (381512)

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

Screen shot from the UCSC genome browser illustrating expression regulation within the identified linkage region on Chromosome 19 (hg18) ( by Rui Lin (219434)

“…From top to bottom: (A) exon level expression fold change in hippocampus (FDR adjusted p value <0.01 and fold change >1.5) between early fetal (periods 3,4 and 5) and postnatal (periods 9,10,11 and 12) from Kang et al 2011, green bars indicate increased expression in fetal compared with postnatal and red bars indicate decreased expression in fetal compared with postnatal. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)